576
Participants
Start Date
March 17, 2021
Primary Completion Date
June 7, 2021
Study Completion Date
December 31, 2021
Bamlanivimab
700 mg/20mL IV over at least one hour OD
Standard of Care
Standard of care includes primary care and specialist care as indicated by the patient's primary care provider
Fraser Health Authority, Fraser Health Region
Lead Sponsor
Fraser Health Authrority Department of Evaluation and Research Services
UNKNOWN
Surrey Memorial Hospital Clinical Research Unit
UNKNOWN
Centre for Health Evaluation and Outcome Sciences
UNKNOWN
Surrey Hospital Foundation
UNKNOWN
BC Support Unit
OTHER
University of British Columbia
OTHER
Ministry of Health, British Columbia
OTHER_GOV
Clinical Trials BC (part of the BC Academic Health Science Network)
UNKNOWN
Fraser Health
OTHER